Modest effect lenvatinib in relapsed osteosarcoma (Gaspar et al., 2024) In children and young adults with recurrent osteosarcoma, the addition of the drug lenvatinib to chemotherapy appeared to suppress tumor growth slightly longer.
Checkpoint inhibitors in the treatment of pediatric solid tumors (Geoerger et al., 2020) In this study researchers determined whether the drug atezolizumab, a so-called checkpoint inhibitor, was active and safe to use in children with solid tumors, including bone tumors.